Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 15 results for "praful bohra"

Market size for Natco's Sorafenib drug is sub $100 mn: Religare

While the Sorafenib drug is not a big opportunity for Natco, approval from Kothur plant is a big positive, says Praful Bohra of Religare Capital Markets. Money Control, 3 weeks ago
India TV

Pharma sector grows 7.7% in May; FDC ban weighs

Mumbai, Jun 12 () Indian pharmaceutical market grew 7.7 per cent in May compared with 3.5 per cent in April, but the ban on fixed-dose combination (FDC) drugs remains an overhang, says a report. According to data from the AIOCD-AWACS, the market ...
 Times of India1 week ago Pharma sector grows 7.7 per cent in May; FDC ban weighs  Pharmaceutical Tech.com1 week ago Pharma Sector Grows 7.7% In May, Drug Ban Weighs: Report  NDTV1 week ago Pharma sector grows 7.7% in May, FDC ban weighs  Financial Express1 week ago
[x]  

Aurobindo Pharma keeps up pace

Related to : Aurobindo Pharma Ltd Aurobindo Pharma Ltd BSE 02 Jun 16 | 12:00 AM 789.50 0.25 (0.03%) NSE 02 Jun 16 | 12:00 AM 788.90 0.05 (0.01%) While pharmaceutical bigwigs such as Sun and Lupin faltered on the bourses after ...
 Smart Investor3 weeks ago Sun Pharma Shares Sink Nearly 7%, Inch Closer To 52-Week Low  NDTV Profit3 weeks ago 'Glenmark to profit from drug price hike, +ve on Sun Pharma'  Money Control1 month ago

Investors Overlook Lupin's Q4 Beat, Shares Tumble Over 9%

Lupin's Goa plant is under US drug regulator's scanner Lupin shares sank over 8 per cent on Friday, even though analysts described the drugmaker's Q4 results as positive. Lupin, India's third-largest drugmaker, reported a higher than expected ...
 NDTV Profit1 month ago Goa plant woes a key overhang on Lupin: Experts  Moneycontrol.com1 month ago

Venezuelan write-offs hit Dr Reddy's Q4 numbers:Experts

Dr Reddy's Pathlabs reported a sharp decline in its net profit of FY16 at Rs 74.6 crore over Rs 518.9 crore a year ago, due to one-time write-offs of Rs 430.9 crore from its Venezuelan business. The company has mentioned in its earnings report that ...
 Moneycontrol.com1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less